Arjo’s climate targets approved by Science Based Targets initiative
Arjo’s climate targets are in line with the latest climate science and the Paris Agreement. This was confirmed by the Science Based Targets initiative (SBTi), which has now validated the company’s climate targets.
“The approval is an important milestone in our sustainability efforts and shows that we have clear targets and a concrete plan to achieve them. We are determined to reduce our climate impact and contribute to the transition to more sustainable healthcare together with our customers and partners,” says Joacim Lindoff, President & CEO of Arjo.
Arjo’s target is to reduce greenhouse gas (GHG) emissions from its own operations (scope 1 and 2) by 50% by 2030. For the value chain (scope 3), the target is to reduce emissions by 25% by 2030. 2021 is the base year for both targets.
Arjo’s GHG emissions from its own operations (Scope 1 and 2) have been reduced by 11% since the base year 2021. A number of initiatives are underway to achieve the targets, focusing on the transition to renewable energy, energy and resource efficiency and the transition to electric vehicles. Arjo is also committed to reducing emissions from the supply chain by collaborating more closely with the Group’s suppliers.
For more information, please contact:
Johan Östblad, Head of Sustainability
Tel: +46 (0)73 684 57 45
Email: [email protected]
About the Science Based Targets initiative
The Science Based Targets initiative (SBTi) is a partnership between CDP, the United Nations Global Compact, the World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). The SBTi drives ambitious climate action by enabling organizations to set science-based emissions reduction targets in line with the Paris Agreement.
About Arjo
At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and over 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com